Purine Content
LevelMedium Risk Purine level: moderate (category estimate)
Sourcescientific_consensus category_estimate
Frequently Asked Questions
What are the purine levels in Restaurant Mexican Refried Beans?
While exact purine measurements for Restaurant Mexican Refried Beans are limited, it is classified as moderate for gout. This assessment is grounded in consensus from the research literature and category-level data. Consult our full review for dietary recommendations.
Does Restaurant Mexican Refried Beans contain fructose?
Restaurant Mexican Refried Beans contains virtually no fructose (less than 0.1g per 100g), so fructose is not a concern for gout with this food. Fructose may drive uric acid up on its own, but this item has almost no fructose to speak of.
Can I eat Restaurant Mexican Refried Beans with gout?
Restaurant Mexican Refried Beans is classified as MODERATE risk for gout. has moderate purine levels. In limited amounts now and then it may be manageable; during a flare, steer clear. Watch your individual reaction and get guidance from a clinician who knows your history.
What food category does Restaurant Mexican Refried Beans belong to?
Restaurant Mexican Refried Beans is classified under Legumes in our gout food database. Its category placement gives helpful framing when comparing foods in your gout diet. Browse other legumes items to compare purine and fructose levels across similar foods.
What are gout-friendly alternatives to Restaurant Mexican Refried Beans?
Instead of Restaurant Mexican Refried Beans, consider choosing legumes options rated SAFE in our gout database — these have low purine (under 50 mg/100g) and low fructose (under 2g/100g). Browse our legumes category page to find the best substitutes for your gout diet plan.
Data Quality
This entry uses T2-level data:
At least one dimension is directly measured; the other is based on scientific consensus.
Sources include USDA FoodData Central (public domain, CC0 1.0), the USDA+ODS-NIH Database for the Purine Content of Foods Release 2.0 (2025), Kaneko et al. Biol Pharm Bull 2014, and ACR/EULAR clinical guidelines.